{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:45:50Z","timestamp":1761093950676,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.7759\/cureus.95054","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:24:24Z","timestamp":1761053064000},"source":"Crossref","is-referenced-by-count":0,"title":["Twelve-Month Survival on Chronic Continuous Milrinone Infusion and Proarrhythmic Complications: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Sachin","family":"Sapkota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu","family":"G. Rajendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishakh","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishnavi","family":"Sabesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyothsna","family":"Goranti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James SL","year":"2018","unstructured":"James SL, Abate D, Abate KH, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018, 392:1789-858. 10.1016\/S0140-6736(18)32279-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese G","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023, 118:3272-87. 10.1093\/cvr\/cvac013","journal-title":"Cardiovasc Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger VL","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021, 128:1421-34. 10.1161\/CIRCRESAHA.121.318172","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.016","article-title":"Inotropes","volume":"63","author":"Francis GS","year":"2014","unstructured":"Francis GS, Bartos JA, Adatya S. Inotropes. J Am Coll Cardiol. 2014, 63:2069-78. 10.1016\/j.jacc.2014.01.016","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.70.6.1030","article-title":"Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone","volume":"70","author":"Monrad ES","year":"1984","unstructured":"Monrad ES, McKay RG, Baim DS, et al.. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation. 1984, 70:1030-7. 10.1161\/01.cir.70.6.1030","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe MS","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF Jr, et al.. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002, 287:1541-7. 10.1001\/jama.287.12.1541","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer M","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ, et al.. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991, 325:1468-75. 10.1056\/NEJM199111213252103","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.08.019","article-title":"Rehospitalization of patients with advanced heart failure receiving continuous, palliative dobutamine or milrinone","volume":"184","author":"Eaton RE","year":"2022","unstructured":"Eaton RE, Kissling KT, Haas GJ, McLaughlin EM, Pickworth KK. Rehospitalization of patients with advanced heart failure receiving continuous, palliative dobutamine or milrinone. Am J Cardiol. 2022, 184:80-9. 10.1016\/j.amjcard.2022.08.019","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.06.006","article-title":"Chronic intravenous inotropic support as palliative therapy and bridge therapy for patients with advanced heart failure: a single-center experience","volume":"27","author":"Rao A","year":"2021","unstructured":"Rao A, Anderson KM, Mohammed S, et al.. Chronic intravenous inotropic support as palliative therapy and bridge therapy for patients with advanced heart failure: a single-center experience. J Card Fail. 2021, 27:974-80. 10.1016\/j.cardfail.2021.06.006","journal-title":"J Card Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.06.323","article-title":"Elevated PVR is associated with improved 6-month survival in patients on continuous milrinone infusion as destination therapy","volume":"20","author":"Cole RT","year":"2014","unstructured":"Cole RT, Patel A, Butler J, Smith A, Book W, Morris A, Gupta D. Elevated PVR is associated with improved 6-month survival in patients on continuous milrinone infusion as destination therapy. J Cardiac Failure. 2014, 20:114. 10.1016\/j.cardfail.2014.06.323","journal-title":"J Cardiac Failure"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure","volume":"9","author":"Hershberger RE","year":"2003","unstructured":"Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003, 9:180-7. 10.1054\/jcaf.2003.24","journal-title":"J Card Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.858076","article-title":"Selection of cardiac transplantation candidates in 2010","volume":"122","author":"Mancini D","year":"2010","unstructured":"Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010, 122:173-83. 10.1161\/CIRCULATIONAHA.109.858076","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2022.2050456","article-title":"Continuous intravenous inotropic support for advanced heart failure: palliative considerations","volume":"36","author":"McPherson A","year":"2022","unstructured":"McPherson A, Nguyen C, Groninger H, Anderson KM, Henderson P, Rao A. Continuous intravenous inotropic support for advanced heart failure: palliative considerations. J Pain Palliat Care Pharmacother. 2022, 36:59-67. 10.1080\/15360288.2022.2050456","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure","volume":"153","author":"Elkayam U","year":"2007","unstructured":"Elkayam U, Tasissa G, Binanay C, et al.. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J. 2007, 153:98-104. 10.1016\/j.ahj.2006.09.005","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham WT","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, et al.. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005, 46:57-64. 10.1016\/j.jacc.2005.03.051","journal-title":"J Am Coll Cardiol"},{"key":"ref17","article-title":"Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study","volume":"33","author":"L\u00f3pez-Candales A","year":"2002","unstructured":"L\u00f3pez-Candales A, Vora T, Gibbons W, Carron C, Simmons P, Schwartz J. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study. J Med. 2002, 33:129-46.","journal-title":"J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.03.019","article-title":"Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis","volume":"6","author":"Nizamic T","year":"2018","unstructured":"Nizamic T, Murad MH, Allen LA, McIlvennan CK, Wordingham SE, Matlock DD, Dunlay SM. Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis. JACC Heart Fail. 2018, 6:757-67. 10.1016\/j.jchf.2018.03.019","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.12.030","article-title":"Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy","volume":"117","author":"Acharya D","year":"2016","unstructured":"Acharya D, Sanam K, Revilla-Martinez M, et al.. Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy. Am J Cardiol. 2016, 117:952-6. 10.1016\/j.amjcard.2015.12.030","journal-title":"Am J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim T","year":"2015","unstructured":"Hashim T, Sanam K, Revilla-Martinez M, et al.. Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure. Circ Heart Fail. 2015, 8:880-6. 10.1161\/CIRCHEARTFAILURE.114.001778","journal-title":"Circ Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422534-twelve-month-survival-on-chronic-continuous-milrinone-infusion-and-proarrhythmic-complications-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:24:24Z","timestamp":1761053064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422534-twelve-month-survival-on-chronic-continuous-milrinone-infusion-and-proarrhythmic-complications-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.95054","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}